Literature DB >> 15715534

Postpartum hemorrhage: a prospective, comparative study in Angola using a new disposable device for oxytocin administration.

Roland T Strand1, Florinda Da Silva, Elisabeth Jangsten, Staffan Bergström.   

Abstract

BACKGROUND: Postpartum hemorrhage (PPH) is the single most common cause of maternal death in the world, and oxytocin is known to be effective for its prevention and treatment. The use of syringes can be problematic in areas affected by HIV. The aim of this study was to introduce Uniject (a new disposable device for administration of 10 IU oxytocin) as part of active management of the third stage of labor (AMTL) and try to reduce PPH.
METHODS: A prospective, comparative study was performed between March 1998 and May 2000 in Luanda. Seven hundred and eighty-two parturient women with physiological management were compared to 814 with AMTL. Postpartum lost blood was collected using a plastic sheet during labor and a bucket placed under a cholera bed for 2 h postpartum. Student's t-test and chi(2) test were used. RESULT: PPH was reduced from 40.4 to 8.2% and severe PPH (> or =1000 ml) from 7.5 to 1% in the AMTL group (P < 0.001).
CONCLUSIONS: Uniject was well tolerated and offers an alternative for oxytocin administration. AMTL should be implemented also in resource-poor settings as a routine management to reduce PPH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15715534     DOI: 10.1111/j.0001-6349.2005.00579.x

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  9 in total

1.  Misoprostol in resource poor countries.

Authors:  Staffan Bergström; Annette Aronsson
Journal:  BMJ       Date:  2008-05-10

Review 2.  What measured blood loss tells us about postpartum bleeding: a systematic review.

Authors:  N L Sloan; J Durocher; T Aldrich; J Blum; B Winikoff
Journal:  BJOG       Date:  2010-04-20       Impact factor: 6.531

3.  Intravenous versus intramuscular prophylactic oxytocin for the third stage of labour.

Authors:  Olufemi T Oladapo; Babasola O Okusanya; Edgardo Abalos; Ioannis D Gallos; Argyro Papadopoulou
Journal:  Cochrane Database Syst Rev       Date:  2020-11-09

4.  Impact on postpartum hemorrhage of prophylactic administration of oxytocin 10 IU via Uniject™ by peripheral health care providers at home births: design of a community-based cluster-randomized trial.

Authors:  Cynthia K Stanton; Samuel Newton; Luke C Mullany; Patience Cofie; Charlotte Tawiah Agyemang; Edward Adiibokah; Niamh Darcy; Sadaf Khan; Alice Levisay; John Gyapong; Deborah Armbruster; Seth Owusu-Agyei
Journal:  BMC Pregnancy Childbirth       Date:  2012-06-07       Impact factor: 3.007

5.  Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis.

Authors:  Andrés Pichon-Riviere; Demián Glujovsky; Osvaldo Ulises Garay; Federico Augustovski; Agustin Ciapponi; Magdalena Serpa; Fernando Althabe
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

6.  Local markets for global health technologies: lessons learned from advancing 6 new products.

Authors:  Dipika Mathur Matthias; Catharine H Taylor; Debjeet Sen; Mutsumi Metzler
Journal:  Glob Health Sci Pract       Date:  2014-05-13

7.  Safety, Tolerability and Pharmacokinetics of Single Doses of Oxytocin Administered via an Inhaled Route in Healthy Females: Randomized, Single-blind, Phase 1 Study.

Authors:  Disala Fernando; Sarah Siederer; Sunita Singh; Ian Schneider; Ashutosh Gupta; Marcy Powell; Duncan Richards; Michelle P McIntosh; Peter Lambert; Susan Fowles
Journal:  EBioMedicine       Date:  2017-07-22       Impact factor: 8.143

Review 8.  Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.

Authors:  Tomas Pantoja; Edgardo Abalos; Evelina Chapman; Claudio Vera; Valentina P Serrano
Journal:  Cochrane Database Syst Rev       Date:  2016-04-14

Review 9.  Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour.

Authors:  Olufemi T Oladapo; Babasola O Okusanya; Edgardo Abalos
Journal:  Cochrane Database Syst Rev       Date:  2018-09-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.